Author Question: The priority assessment for the Rh-positive infant whose mother's indirect Coombs test was positive ... (Read 16 times)

sarasara

  • Hero Member
  • *****
  • Posts: 521
The priority assessment for the Rh-positive infant whose mother's indirect Coombs test was positive at 36 weeks is:
 
  a. skin color.
  b. temperature.
  c. respiratory rate.
  d. blood glucose level.

Question 2

The nurse should be alert to a blood group incompatibility if:
 
  a. both mother and infant are O-positive.
  b. mother is A-positive and infant is A-negative.
  c. mother is O-positive and infant is B-negative.
  d. mother is B-positive and infant is O-negative.



flannelavenger

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

ANS: A
An Rh-negative infant whose mother was sensitized during the current pregnancy will have decreased red blood cells (RBCs) and exhibit skin pallor because of erythroblastosis fetalis. The temperature, respiratory rate, and blood glucose level are not assessments associated with erythroblastosis fetalis.

Answer to Question 2

ANS: D
Blood group incompatibilities occur because O-positive mothers have natural antibodies to type A or B blood. When mother and infant both have blood group O or A, no incompatibility exists. The mother with blood group B does not have any antibodies to group O.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

For a complete list of videos, visit our video library